1,862 results on '"Umpierrez, Guillermo"'
Search Results
52. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive Summary
53. Outcomes With Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Baseline Insulin Resistance
54. Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine and Glycated Albumin in Patients with End-Stage Kidney Disease and Burnt-Out Diabetes
55. Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes
56. Beyond pounds: What else could be lost?
57. Letter to the Editor from Tayek and Umpierrez: “New Onset or Stress Hyperglycemia and Hospital Mortality Risk”
58. Use of Continuous Glucose Monitors Upon Hospital Discharge of People With Diabetes: Promise, Barriers, and Opportunity
59. Coverage for Continuous Glucose Monitoring for Individuals with Type 2 Diabetes Treated with Nonintensive Therapies: An Evidence-Based Approach to Policymaking
60. Latent tuberculosis infection among patients with and without type-2 diabetes mellitus: results from a hospital case-control study in Atlanta
61. Implementation of App-Based Diabetes Medication Management: Outpatient and Perioperative Clinical Decision Support
62. Efficacy and Safety of Iglarlixi in Hispanics and Non-Hispanic Whites with Type 2 Diabetes
63. Associations of childhood trauma with food addiction and insulin resistance in African-American women with diabetes mellitus
64. Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State
65. The differential effects of PTSD, MDD, and dissociation on CRP in trauma-exposed women
66. Transcultural Diabetes Care in The United States – A Position Statement by the American Association of Clinical Endocrinologists
67. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2019 Executive Summary
68. Glycemic Variability: How to Measure and Its Clinical Implication for Type 2 Diabetes
69. Outcomes With Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Baseline Insulin Resistance.
70. Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes.
71. Glucose Control in the ICU
72. Prevalence of Sarcopenia in Insulin Treated Older Adults with Type 2 Diabetes
73. A Consensus Statement for Continuous Glucose Monitoring Metrics for Inpatient Clinical Trials
74. Use of Continuous Glucose Monitoring in Insulin-Treated Older Adults with Type 2 Diabetes
75. The Growing Role of Technology in the Care of Older Adults With Diabetes
76. A Randomized Controlled Trial Comparing the Efficacy and Safety of IDegLira versus Basal-Bolus in Patients with Poorly Controlled Type 2 Diabetes and Very High HbA1c > 9-15%: DUAL HIGH trial
77. A Randomized Controlled Trial Comparing the Efficacy and Safety of IDegLira Versus Basal-Bolus in Patients With Poorly Controlled Type 2 Diabetes and Very High HbA1c ≥9–15%: DUAL HIGH Trial
78. Diabetic retinopathy in African–Americans with end-stage kidney disease: a cross-sectional study on prevalence and impact on quality of life
79. Switching to insulin glargine 300 U/mL: Is duration of prior basal insulin therapy important?
80. Diabetes Complications in Racial and Ethnic Minority Populations in the USA
81. The Efficacy and Safety of Co-Administration of Sitagliptin With Metformin in Patients With Type 2 Diabetes at Hospital Discharge
82. A Randomized Controlled Study Comparing a DPP4 Inhibitor (Linagliptin) and Basal Insulin (Glargine) in Patients With Type 2 Diabetes in Long-term Care and Skilled Nursing Facilities: Linagliptin-LTC Trial
83. American Association of Clinical Endocrinologists And American College of Endocrinology 2018 Position Statement On Integration of Insulin Pumps And Continuous Glucose Monitoring In Patients With Diabetes Mellitus
84. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary
85. Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action.
86. Safety and Efficacy of DPP4 Inhibitor and Basal Insulin in Type 2 Diabetes: An Updated Review and Challenging Clinical Scenarios
87. Diabetic ketoacidosis
88. Aace/ace Position Statement on the use of follow-on Biologics and Biosimilars for Endocrine Diseases
89. 210 - Diabetes Mellitus
90. Relationship between body weight change and glycaemic control with tirzepatide treatment in people with type 2 diabetes: A post hoc assessment of the SURPASS clinical trial programme
91. Real-World Study on the Use of Continuous Glucose Monitoring in Insulin-Treated Older Adults with Type 2 Diabetes
92. National Trends in Glucagon Prescriptions Among U.S. Adults With Diabetes and End-Stage Kidney Disease Treated by Dialysis: 2013–2017
93. Comparison of Efficacy and Safety of Glargine and Detemir Insulin in the Management of Inpatient Hyperglycemia and Diabetes
94. Diabetic Ketoacidosis: A Common Debut of Diabetes Among African Americans With Type 2 Diabetes
95. Perspectives on Learning and Clinical Practice Improvement for Diabetes in the Hospital: A Review of Educational Interventions for Providers
96. Management of Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State
97. Social vulnerability and hypoglycemia among patients with diabetes
98. Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial
99. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive type 2 Diabetes Management Algorithm – 2017 Executive Summary
100. Approaches To Insulin Use
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.